Prescription Drug Misuse: Clinical Trials

7 trials for Prescription Drug Misuse, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting, 2 terminated. 7 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Not yet recruiting 2, Terminated 2
Phase 11Completed 1

Follow Prescription Drug Misuse: new trials by email Literature Review of Prescription Drug Misuse trials Research Report on Prescription Drug Misuse

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Naloxone for Opioid Associated Out of Hospital Cardiac Arrest
Naloxone 2 MG, Saline 2ml - Heart Arrest, Out-Of-Hospital, Opioid Overdose
Phase 2Not yet recruitingUniversity of California, San Francisco982027-03-012026-09-11
Serious Game to Teach Opioid Overdose Response
Serious game training - Opioid Overdose
Phase 2Not yet recruitingUniversity of Nevada, Reno8502026-02-012024-12-11
Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdose
Intravenous infusion of N-acetylcysteine, Intravenous infusion of Fomepizole (4-MP) - Acetaminophen, Drug Overdose
Phase 2TerminatedRichard Dart, MD, PhD292022-09-122025-11-25
Vaped Marijuana to Attenuate Naloxone-Precipitated Withdrawal
Naloxone, Marijuana - Opioid Overdose
Phase 2TerminatedNew York State Psychiatric Institute22021-11-012025-03-18
Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use
Intranasal naloxone, Intramuscular naloxone, Remifentanil - Drug Overdose
Phase 1 / Phase 2CompletedNorwegian University of Science and Technology122014-12-012018-10-17
A Pilot Study of the Bioavailability of Nasal Naloxone
naloxone intranasal, naloxone intravenous - Drug Overdose
Phase 2CompletedNorwegian University of Science and Technology52013-08-012021-11-03
Randomized Trial of Intranasal Versus Intravenous Naloxone in Level of Consciousness in Suspected Opioid Overdose
Intranasal naloxone, Intravenous - Morphinan Opioid Overdose
Phase 2CompletedIsfahan University of Medical Sciences1002007-03-012011-02-10

Narrower conditions

Drug Overdose (4)  ·  Opiate Overdose (3)  ·  Chemical and Drug Induced Liver Injury (1)  ·  Liver Failure (1)  ·  Out-of-Hospital Cardiac Arrest (1)

Broader conditions

Chemically-Induced Disorders (7)  ·  Drug Misuse (7)  ·  Mental Disorders (7)  ·  Substance-Related Disorders (7)  ·  Drug Overdose (3)  ·  Narcotic-Related Disorders (3)  ·  Opioid-Related Disorders (3)  ·  Cardiovascular Diseases (1)  ·  Digestive System Diseases (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Heart Arrest (1)  ·  Heart Diseases (1)  ·  Hepatic Insufficiency (1)  ·  Liver Diseases (1)

Interventions

Naloxone (2)  ·  4-methylpiperazine-2,6-dione (1)  ·  Remifentanil (1)  ·  Sodium Chloride (1)  ·  nabiximols (1)

Sponsors

Norwegian University of Science and Technology (2)  ·  Isfahan University of Medical Sciences (1)  ·  New York State Psychiatric Institute (1)  ·  Richard Dart, MD, PhD (1)  ·  University of California, San Francisco (1)  ·  University of Nevada, Reno (1)

Countries

United States (3)  ·  Norway (2)  ·  Iran (1)

Top investigators

Jermaine Jones, PhD (1)  ·  Nastaran Izadi, A.Professor (1)  ·  Ralph Wang, MD, MAS (1)  ·  Richard Dart, MD, PhD (1)  ·  Toril A Nagelhus Hernes, phd prof (1)

Results publications

PMID 29568976, PMID 31556537, PMID 37681263, PMID 40839512

NIH funding

2014 (1)